Discordance between testosterone measurement methods in castrated prostate cancer patients

Failure to suppress testosterone below 0.7 nM in castrated prostate cancer patients is associated with poor clinical outcomes. Testosterone levels in castrated patients are therefore routinely measured. Although mass spectrometry is the gold standard used to measure testosterone, most hospitals use...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Endocr Connect
Päätekijät: Rouleau, Mélanie, Lemire, Francis, Déry, Michel, Thériault, Benoît, Dubois, Gabriel, Fradet, Yves, Toren, Paul, Guillemette, Chantal, Lacombe, Louis, Klotz, Laurence, Saad, Fred, Guérette, Dominique, Pouliot, Frédéric
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Bioscientifica Ltd 2019
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6376995/
https://ncbi.nlm.nih.gov/pubmed/30673630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0476
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia